Moderna Recovers, But Muted Expectations Haunt Cancer Vaccine
Moderna stock yo-yoed Monday on more muted expectations for its Merck-partnered cancer vaccine, INT.
- Moderna Recovers From 10% Dive, But Muted Expectations Haunt Cancer Vaccine · investors.com · about 19 hours ago
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why. · marketwatch.com · about 19 hours ago